Correlation Between Visa and Humacyte
Can any of the company-specific risk be diversified away by investing in both Visa and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Humacyte, you can compare the effects of market volatilities on Visa and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Humacyte.
Diversification Opportunities for Visa and Humacyte
Very good diversification
The 3 months correlation between Visa and Humacyte is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Visa i.e., Visa and Humacyte go up and down completely randomly.
Pair Corralation between Visa and Humacyte
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.33 times more return on investment than Humacyte. However, Visa Class A is 3.07 times less risky than Humacyte. It trades about 0.6 of its potential returns per unit of risk. Humacyte is currently generating about -0.34 per unit of risk. If you would invest 32,309 in Visa Class A on November 22, 2024 and sell it today you would earn a total of 3,214 from holding Visa Class A or generate 9.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Visa Class A vs. Humacyte
Performance |
| Timeline |
| Visa Class A |
| Humacyte |
Visa and Humacyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and Humacyte
The main advantage of trading using opposite Visa and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| Humacyte vs. Crinetics Pharmaceuticals | Humacyte vs. Viridian Therapeutics | Humacyte vs. Cytokinetics | Humacyte vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |